Observational studyMedicine2017
True rise in anaphylaxis incidence: Epidemiologic study based on a national health insurance database.
Observational study in Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Global Burden of Drug-Induced Anaphylaxis Associated With 33 Classes of Antibiotics (1968-2024): A Pharmacovigilance Analysis.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025Article
- The Application of Knowledge-Based Clinical Decision Support Systems to Detect Antibiotic Allergy.Antibiotics (Basel, Switzerland) · 2024Article
- Article
- Positive Predictive Values of Anaphylaxis Diagnosis in Claims Data: A Multi-Institutional Study in Taiwan.Journal of medical systems · 2023Article
- Contemporary trends in anaphylaxis burden and healthcare utilisation in Western Australia: A linked data study.The World Allergy Organization journal · 2023Article
- Population-based incidence of all-cause anaphylaxis and its development over time: a systematic review and meta-analysis.Frontiers in allergy · 2023Review
- Risk factors of anaphylaxis in Korea: Identifying drug-induced anaphylaxis culprits using big data.Medicine · 2022Article
- Article
- Environmental Influences and Allergic Diseases in the Asia-Pacific Region: What Will Happen in Next 30 Years?Allergy, asthma & immunology research · 2022Review
- Pilot Project of Special Emergency Medical Service Team for Anaphylaxis in Gangwon-do, Korea: Results from an Online Questionnaire Survey.Journal of Korean medical science · 2021Article
- Recent update on the management of anaphylaxis.Clinical and experimental emergency medicine · 2021Article
- Risk factors of beta-lactam anaphylaxis in Korea: A 6-year multicenter retrospective adult case-control study.The World Allergy Organization journal · 2021Article
- The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.Vaccine · 2021Article
- Estimating Baseline Incidence of Conditions Potentially Associated with Vaccine Adverse Events: a Call for Surveillance System Using the Korean National Health Insurance Claims Data.Journal of Korean medical science · 2021Article
- Anaphylaxis: Five Years' Experience in the Emergency Rooms of Five University Hospitals in Korea.Medicina (Kaunas, Lithuania) · 2020Article
- A multicenter anaphylaxis registry in Korea: Clinical characteristics and acute treatment details from infants to older adults.The World Allergy Organization journal · 2020Article
- Intranasal epinephrine effects on epinephrine pharmacokinetics and heart rate in a nasal congestion canine model.Respiratory research · 2020Article
- Prevalence of anaphylaxis and prescription rates of epinephrine auto-injectors in urban and rural areas of Korea.The Korean journal of internal medicine · 2019Article
- Common causes of emergency department visits for anaphylaxis in Korean community hospitals: A cross-sectional study.Medicine · 2019Article
- HumanAsia Pacific allergy · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence trend of anaphylaxis in Asia is not well investigated. The aim of this study is to estimate the entire population-based incidence of anaphylaxis in Korea using a nationwide administrative database.Data over a 7-year period (2008-2014) was obtained from the Korean National Health Insurance (NHI) claims database which covers 97.9% of the entire Korean population. Using diagnosis codes from the International Classification of Diseases-10 for anaphylaxis (T78.0, T78.2, T80.5, and T88.6), we identified the annual number of patients who had visited any hospital with a primary diagnosis of anaphylaxis. Incidence rates were calculated using the population distribution data of all NHI beneficiaries.The incidence of anaphylaxis in Korea was 32.19 episodes per 100,000 person-years in 2014, which nearly doubled from 2008 (16.02 episodes per 100,000 person-years). The incidence of anaphylaxis increased continuously throughout these years regardless of gender and age groups (P for trend < 0.001). Female was significantly less predisposed than male (adjusted odds ratio [OR], 0.69; 95% confident interval [CI], 0.66-0.72; P < 0.001). The incidence was the lowest in 0 to 19 age group and the highest in 40 to 69 age group (adjusted OR, 2.41; 95% CI, 2.29-2.54; P < 0.001).In conclusion, we report the increasing time trend of anaphylaxis incidence rates using nationwide claims database for the first time in Asia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.